Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

BACKGROUND: This study aimed to verify the safety and efficacy, including glycemic control, of the selective dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes. METHODS: This study used a multi-center, open-label, prospective observational design. Type 2 diabetes patients w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med Res
Autori principali: Takamiya, Yosuke, Kobayashi, Kunihisa, Kudo, Tadachika, Okuda, Tetsu, Okamura, Keisuke, Shirai, Kazuyuki, Urata, Hidenori
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elmer Press 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331869/
https://ncbi.nlm.nih.gov/pubmed/32655736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4224
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi